The ZOHé study was a prospective, non-interventional, multicentre study in France to assess the use of biosimilar filgrastim Zarzio® (Sandoz filgrastim) in routine clinical practice in patients at risk of neutropeniainducing chemotherapy (CT). | Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia A prospective multicentre study in France in patients with solid tumours the ZOHé study